Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion type Assertion NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_head.
- NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion wasGeneratedBy ECO_0000203 NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_provenance.
- NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion wasDerivedFrom befree-20150227 NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_provenance.
- NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion SIO_000772 24344117 NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_provenance.
- NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion evidence source_evidence_literature NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_provenance.
- NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_provenance.